Description

Hexarelin – 5 mg

(Growth Hormone Releasing Peptide Analog)

Hexarelin is a potent synthetic hexapeptide and member of the growth hormone secretagogue (GHS) family, closely related to GHRP-2 and GHRP-6. It acts as a selective agonist of the ghrelin receptor (GHS-R1a), stimulating the pituitary gland to release endogenous growth hormone (GH) in a pulsatile manner.

Compared to other GHRPs, Hexarelin is noted for its higher GH-releasing potency and consistent response even with repeated dosing in research models. It has been widely investigated for its potential roles in muscle repair, metabolic regulation, and cardiovascular protection.

---

Mechanism of Action (Based on Preclinical and Clinical Research):

• Ghrelin receptor activation: Binds selectively to GHS-R1a, triggering GH release from the anterior pituitary.

• Synergistic GH release: Enhances pulsatile GH secretion and may increase IGF-1 production.

• Anabolic signaling: Supports protein synthesis and tissue regeneration via GH/IGF-1 pathways.

• Cardioprotective effects: Studied for myocardial and vascular protective properties in experimental models.

• Metabolic influence: May improve lipid and glucose metabolism while supporting cellular recovery.

---

Potential Benefits (Based on Preclinical Research):

• Sustained elevation of endogenous GH levels

• Promotion of muscle growth and tissue recovery

• Support for cardiac and vascular function

• Enhanced metabolic activity and fat utilization

• Synergistic applications with GHRH analogs (e.g., CJC-1295) in GH-releasing studies

• Explored for regenerative and performance-related biological research

---

For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory agency and is intended solely for laboratory research.